Contact US

GEDSA Releases Conclusive August 2016 Position Statement

As a summary of previous Position Statements, GEDSA re-emphasizes recom­men­da­tions including:

“Performance testing conducted by an accred­ited third party lab and usability studies conducted throughout the world confirm the ENFit LDT syringe when used as instructed:

  • Delivers an accu­rate dose substan­tially equiv­a­lent with current male orien­tated enteral/oral syringes.
  • Outperforms existing female (reverse) orien­tated syringes.
  • Fits into current prac­tice and main­tains compat­i­bility with other ENFit devices”Furthermore, the August GEDSA Position Statement recom­mends:

“GEDSA and its supporting orga­ni­za­tions including the Joint Commission, ISMP, ASHP, ASPEN, NHS, and EPSG encourage manu­fac­turers to intro­duce enteral devices with ENFit connec­tors, and health­care facil­i­ties to:

  • Adopt feeding systems with ENFit connec­tors as soon as possible.
  • Use ENFit LDT syringes to ensure accu­rate dose delivery of small volumes.
  • Work with your supplier repre­sen­ta­tive and distrib­utor network to under­stand their specific timing and product avail­ability for tran­si­tion.
  • Confirm syringe suppliers have adequate supplies of stan­dard and LDT ENFit syringes before converting to ENFit feeding tubes”

A new and signif­i­cant recom­men­da­tion is included by GEDSA:

“In order to obtain the requi­site dose accu­racy, manu­fac­turers of ENFit LDT syringes should specify in their instruc­tions for use and labeling that the syringe user should remove fluid that lies outside of the fluid path. The area between the male lumen and the outer ring (the “moat”) is not part of the fluid path and should be free of fluid. For settings that require highly accu­rate low volume doses, an ENFit LDT Syringe is recom­mended. The ENFit LDT syringe tip design satis­fies the perfor­mance expec­ta­tions for dose accu­racy, dead space, and toler­ance on grad­u­ated capacity.”

NeoMed’s inno­v­a­tive prod­ucts include DoseMate, an ergonomic tip, which prevents fluid accu­mu­la­tion in the moat during direct oral admin­is­tra­tion.
NM-SMM-099 Rev 6